Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Hubbard

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Journal of Pharmaceutical Sciences|February 1, 1993
Logarithmic transformation in bioequivalence: application with two formulations of perphenazineK K Midha, E D Ormsby, J W Hubbard, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6D Young, K K Midha, M J Fossler, et al.
Psychopharmacology Bulletin|January 1, 1989
Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazineS R Marder, T Van Putten, M Aravagiri, et al.
Therapeutic Drug Monitoring|May 1, 1990
Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassayM Aravagiri, S R Marder, T Van Putten, et al.
Biopharmaceutics & Drug Disposition|January 1, 1984
A bioequivalency study of two trifluoperazine tablet formulations using RIA and GC-MSK K Midha, E M Hawes, E D Korchinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
alpha-Adrenergic activity and cardiovascular effects of besipirdine HCl (HP 749) and metabolite P7480 in vitro and in the conscious rat and dogJ W Hubbard, S T Nordstrom, C P Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 1991
Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinityJ W Hubbard, P G Conway, L C Nordstrom, et al.
Psychopharmacology|January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoateK K Midha, J W Hubbard, S R Marder, et al.
Journal of Pharmacological Methods|March 1, 1988
Radioimmunoassay for fluphenazine sulfoxide in human plasmaK K Midha, E M Hawes, J W Hubbard, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Stereoselective pharmacokinetics of doxepin isomersK K Midha, J W Hubbard, G McKay, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Journal of Pharmaceutical Sciences|February 1, 1993
Logarithmic transformation in bioequivalence: application with two formulations of perphenazineK K Midha, E D Ormsby, J W Hubbard, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6D Young, K K Midha, M J Fossler, et al.
Psychopharmacology Bulletin|January 1, 1989
Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazineS R Marder, T Van Putten, M Aravagiri, et al.
Therapeutic Drug Monitoring|May 1, 1990
Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassayM Aravagiri, S R Marder, T Van Putten, et al.
Biopharmaceutics & Drug Disposition|January 1, 1984
A bioequivalency study of two trifluoperazine tablet formulations using RIA and GC-MSK K Midha, E M Hawes, E D Korchinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
alpha-Adrenergic activity and cardiovascular effects of besipirdine HCl (HP 749) and metabolite P7480 in vitro and in the conscious rat and dogJ W Hubbard, S T Nordstrom, C P Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 1991
Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinityJ W Hubbard, P G Conway, L C Nordstrom, et al.
Psychopharmacology|January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoateK K Midha, J W Hubbard, S R Marder, et al.
Journal of Pharmacological Methods|March 1, 1988
Radioimmunoassay for fluphenazine sulfoxide in human plasmaK K Midha, E M Hawes, J W Hubbard, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Stereoselective pharmacokinetics of doxepin isomersK K Midha, J W Hubbard, G McKay, et al.
Pageof 12